Company Filing History:
1 out of 832,891 Years Active: 2003
Title: Foy Dean Miller: Innovator in Amyloid-Associated Disorders
Introduction
Foy Dean Miller is an accomplished inventor based in Camby, Indiana. He has made significant contributions to the field of medical research, particularly in the prevention and treatment of amyloid-associated disorders. His innovative work focuses on understanding microglial cell activation and its implications for various diseases.
Latest Patents
Foy Dean Miller holds a patent for the invention titled "Prevention and treatment of amyloid-associated disorders." This patent provides assays designed to identify compounds that affect microglial cell activation. Specifically, the invention includes assays for testing microglial cell activation by contacting microglia with compounds that modulate β-amyloid PGE-mediated activation. The assays can identify candidate compounds by measuring cellular activity, such as the secretion of cytokines like TNF-α and IL-1α. The effectiveness of these compounds can be determined by comparing their effects with a control culture or a standardized profile.
Career Highlights
Throughout his career, Foy Dean Miller has demonstrated a commitment to advancing medical science through his innovative research. His work has the potential to impact the treatment of various amyloid-associated disorders, contributing to improved patient outcomes.
Collaborations
Foy Dean Miller has collaborated with notable colleagues, including Paul Andrew Hyslop and Linda Shawn Higgins. These partnerships have enhanced the scope and impact of his research efforts.
Conclusion
Foy Dean Miller is a notable inventor whose work in the field of amyloid-associated disorders showcases his dedication to medical innovation. His patent reflects a significant advancement in understanding microglial cell activation and its role in disease treatment.